Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/49863 |
Resumo: | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (BioManguinhos). Laboratório de Tecnologia Imunobiológica. Rio de Janeiro, RJ, Brasil. |
id |
CRUZ_55e183ae5c07feb07e1c940c0160ced3 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/49863 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Homma, AkiraCarvalho, Antônio Carlos Campos deFialho, Beatriz de CastroGadelha, Carlos Augusto GraboisToscano, Cristiana MariaKrieger, Marco AurélioSiqueira, Marilda Agudo Mendonça Teixeira deGoldbaum, MoisésLima, Nísia TrindadeSavino, Wilson2021-11-17T21:18:43Z2021-11-17T21:18:43Z2021HOMMA, Akira et al. Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice. The Lancet Regional Health - Americas, v. 1, 100020, p. 1-2, July 2021.2667-193Xhttps://www.arca.fiocruz.br/handle/icict/4986310.1016/j.lana.2021.100020engElsevierCOVID-19Fabricação de vacinasVacina P&DProdução localCOVID-19Vaccine manufacturingVaccine R&DLocal productionDevelopment challengesDeveloping countriesDesafios de desenvolvimentoPaíses em desenvolvimentoCovid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practiceinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (BioManguinhos). Laboratório de Tecnologia Imunobiológica. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ. Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (BioManguinhos). Laboratório de Tecnologia Imunobiológica. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (BioManguinhos). Instituto de Tecnologia Imunobiológica. Conselheiro Executivo do Conselho de Administração. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Presidência. Centro de Estudos Estratégicos. Rio de Janeiro, RJ, Brasil.Universidade Federal de Goiás. Departamento de Saúde Coletiva. Goiânia, GO, Brasil.Fundação Oswaldo Cruz. Presidência. Vice-Presidente de Produção e Inovação para Saúde. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratório e do Sarampo. Rio de Janeiro, RJ, Brasil.Universidade de São Paulo. Faculdade de Medicina. Departamento de Medicina Preventiva. São Paulo, SP, Brasil.Fundação Oswaldo Cruz. Presidência. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Coordenação de Estratégias de Integração Regional e Nacional. Rio de Janeiro, RJ, Brasil.Covid-19 has hit more than 170 million people, with more than 3.5 million deaths [1] . It continues to evolve and spread across the planet and the SARS-CoV-2 variants of concern represent a further threat for global health security.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/49863/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALMarildaSiqueira_WilsonSavino_etal_IOC_2021.pdfMarildaSiqueira_WilsonSavino_etal_IOC_2021.pdfapplication/pdf239844https://www.arca.fiocruz.br/bitstream/icict/49863/2/MarildaSiqueira_WilsonSavino_etal_IOC_2021.pdfff0f3f4b56b9a4d303b5088eb590998fMD52icict/498632023-02-23 15:59:30.3oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-02-23T18:59:30Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice |
title |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice |
spellingShingle |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice Homma, Akira COVID-19 Fabricação de vacinas Vacina P&D Produção local COVID-19 Vaccine manufacturing Vaccine R&D Local production Development challenges Developing countries Desafios de desenvolvimento Países em desenvolvimento |
title_short |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice |
title_full |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice |
title_fullStr |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice |
title_full_unstemmed |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice |
title_sort |
Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice |
author |
Homma, Akira |
author_facet |
Homma, Akira Carvalho, Antônio Carlos Campos de Fialho, Beatriz de Castro Gadelha, Carlos Augusto Grabois Toscano, Cristiana Maria Krieger, Marco Aurélio Siqueira, Marilda Agudo Mendonça Teixeira de Goldbaum, Moisés Lima, Nísia Trindade Savino, Wilson |
author_role |
author |
author2 |
Carvalho, Antônio Carlos Campos de Fialho, Beatriz de Castro Gadelha, Carlos Augusto Grabois Toscano, Cristiana Maria Krieger, Marco Aurélio Siqueira, Marilda Agudo Mendonça Teixeira de Goldbaum, Moisés Lima, Nísia Trindade Savino, Wilson |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Homma, Akira Carvalho, Antônio Carlos Campos de Fialho, Beatriz de Castro Gadelha, Carlos Augusto Grabois Toscano, Cristiana Maria Krieger, Marco Aurélio Siqueira, Marilda Agudo Mendonça Teixeira de Goldbaum, Moisés Lima, Nísia Trindade Savino, Wilson |
dc.subject.other.pt_BR.fl_str_mv |
COVID-19 Fabricação de vacinas Vacina P&D Produção local |
topic |
COVID-19 Fabricação de vacinas Vacina P&D Produção local COVID-19 Vaccine manufacturing Vaccine R&D Local production Development challenges Developing countries Desafios de desenvolvimento Países em desenvolvimento |
dc.subject.en.pt_BR.fl_str_mv |
COVID-19 Vaccine manufacturing Vaccine R&D Local production Development challenges Developing countries Desafios de desenvolvimento Países em desenvolvimento |
description |
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (BioManguinhos). Laboratório de Tecnologia Imunobiológica. Rio de Janeiro, RJ, Brasil. |
publishDate |
2021 |
dc.date.accessioned.fl_str_mv |
2021-11-17T21:18:43Z |
dc.date.available.fl_str_mv |
2021-11-17T21:18:43Z |
dc.date.issued.fl_str_mv |
2021 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
HOMMA, Akira et al. Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice. The Lancet Regional Health - Americas, v. 1, 100020, p. 1-2, July 2021. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/49863 |
dc.identifier.issn.pt_BR.fl_str_mv |
2667-193X |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.lana.2021.100020 |
identifier_str_mv |
HOMMA, Akira et al. Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice. The Lancet Regional Health - Americas, v. 1, 100020, p. 1-2, July 2021. 2667-193X 10.1016/j.lana.2021.100020 |
url |
https://www.arca.fiocruz.br/handle/icict/49863 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/49863/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/49863/2/MarildaSiqueira_WilsonSavino_etal_IOC_2021.pdf |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 ff0f3f4b56b9a4d303b5088eb590998f |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008951436902400 |